trial · primary record
sunvozertinib
Non-small Cell Lung Cancer
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 324 |
| Primary completion | 2027-10-31 |
| Primary endpoint | Progression Free Survival (PFS) as assessed by Blinded Independent Central Review (BICR) per RECIST 1.1 |
| Registry ID | NCT05668988 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:24.200Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05668988
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- SUNVOZERTINIB · approval
- Sunvozertinib · compound